KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

BioNTech SE (BNTX) Consolidated Net Income (2018 - 2025)

BioNTech SE's Consolidated Net Income history spans 8 years, with the latest figure at -$355.0 million for Q4 2025.

  • On a quarterly basis, Consolidated Net Income fell 228.03% to -$355.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.3 billion, a 54.73% decrease, with the full-year FY2025 number at -$1.3 billion, down 74.06% from a year prior.
  • Consolidated Net Income hit -$355.0 million in Q4 2025 for BioNTech SE, down from -$33.6 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for BNTX hit a ceiling of $4.2 billion in Q1 2022 and a floor of -$869.9 million in Q2 2024.
  • Historically, Consolidated Net Income has averaged $1.1 billion across 5 years, with a median of $406.5 million in 2023.
  • Biggest five-year swings in Consolidated Net Income: soared 827987404.69% in 2021 and later tumbled 319.57% in 2024.
  • Tracing BNTX's Consolidated Net Income over 5 years: stood at $3.6 billion in 2021, then increased by 14.54% to $4.1 billion in 2022, then plummeted by 88.13% to $492.7 million in 2023, then crashed by 43.72% to $277.3 million in 2024, then crashed by 228.03% to -$355.0 million in 2025.
  • Business Quant data shows Consolidated Net Income for BNTX at -$355.0 million in Q4 2025, -$33.6 million in Q3 2025, and -$474.1 million in Q2 2025.